FDA pharmacologic class
Echinocandin Antifungal
4 medicines are in FDA's class of echinocandin antifungals: micafungin, caspofungin (Cancidas), anidulafungin (Eraxis) and rezafungin (Rezzayo). 2 of the 4 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are echinocandin antifungal?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Micafungin | none listed | 10 labelers | n/a | No | A presentation being discontinued | 4 |
| Caspofungin | Cancidas | 5 labelers | n/a | No | A presentation being discontinued | 0 |
| Anidulafungin | Eraxis | none listed | n/a | No | No current entry | 0 |
| Rezafungin | Rezzayo | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)